Thanksgiving Holiday Service Hours
In recognition of the upcoming Thanksgiving holiday, many of The University of Cancer Center's offices will have modified hours during this time.
KU Medical Center researchers receive R01 grant from National Cancer Institute to increase targeted cancer treatments to rural cancer patients
TEAMSPORT will create a standardized approach to ordering genomic tests and adapt it for use in community cancer centers, where most cancer patients receive testing and treatment.
Lymphedema Program Receives Elite Honor
The University of Kansas Cancer Center lymphedema program was recently named a Comprehensive Center of Excellence in the diagnosis and treatment of lymphatic disease.
Inaugural Associate Director for Cancer Workforce Equity Named
Megha Ramaswamy, PhD, MPH, will serve as Associate Director for Cancer Workforce Equity.
2022 Directors Award and Pilot Award Recipients
The University of Kansas Cancer Center announced its 2022 recipients of the Director’s Awards, which recognizes individuals who have made significant contributions to the cancer center’s mission, and Pilot Awards, which funds promising novel research being conducted by cancer center members.
The University of Kansas Cancer Center Partners with Nation’s Top Cancer Organizations to Endorse Initiative to Increase Lung Cancer Screening in the United States
Joint call to action urges individuals, providers and insurers to increase access to and utilization of low-dose CT screening for those at high risk for lung cancer
Cancer center investigators recognized for clinical trial enrollment
Clinicians and researchers recently received recognition for clinical trial accruals through the National Cancer Institute’s (NCI) National Community Oncology Research Program (NCORP).
Cancer center joins exclusive clinical trials network
Experimental Therapeutics Clinical Trials Network (ETCTN) membership will increase the number of early-stage clinical trials KU Cancer Center can offer to people with cancer.
Kansas Governor issues proclamation to honor The University of Kansas Cancer Center’s earning highest designation from the National Cancer Institute
The cancer center is one of just 53 centers in the country to be awarded Comprehensive status from the NCI.
Researcher receives $1.9M Maximizing Investigators' Research Award from NIH
The five-year grant will fund research studying a protein associated with the development of cancer and other diseases.
Researchers identify potential target to treat AML
KU Cancer Center researchers contributed to Beat AML study
The University of Kansas Cancer Center earns National Cancer Institute’s most prestigious status — Comprehensive
KU Cancer Center has been designated as a “Comprehensive” cancer center by the NCI, the highest level of recognition awarded and the gold standard for cancer centers.
Varenicline increases smoking cessation rates for African American smokers
African Americans have disproportionately high rates of tobacco-related disease, making treatment critical.